Leadership, Planning and Evaluation

项目总结：领导、规划和评估 斯蒂芬·D医学博士尼莫于2012年被任命为西尔维斯特综合癌症中心（西尔维斯特）主任。 在他的领导下，西尔维斯特经历了指数级增长，其敬业的领导团队， 其高度参与和经验丰富的外部咨询委员会（EAB），其与大学的生产关系 领导力，并坚持精心制定的2014 - 2018年战略计划，制定明确的标准， 时间表、目标和可交付成果。尼莫在一个高级领导团队的协助下领导着西尔维斯特 包括一名副主任、六名协理主任、一名协理副总裁和一名总医师 肿瘤服务热线总的来说，这个小组为主任提供了周到和重要的咨询意见， 包括促进西尔维斯特的基础、转化、临床和人口科学发展的战略 研究组合;教育和培训活动;社区外联和参与能力;共享 资源支持;以及确定新研究方向和创建新项目和资金的能力 为会员提供机会。除了西尔维斯特强大的高级领导团队提供的指导外， 西尔维斯特有七个内部审查委员会，提供建议，并监督 执行西尔维斯特的活动和战略计划;包括执行委员会，空间 分配，校内资助计划（IFP），科学指导委员会（SSC），临床研究内部 咨询委员会（CRIAB）、癌症教育领导理事会（CELC）和社区外展和 参与内部咨询委员会（COE IAB）。此外，两个外部咨询实体-外部 咨询委员会（EAB）和监督委员会（BOO）-提供咨询和专业知识， 西尔维斯特的成功补充西尔维斯特的高级领导和内部和外部咨询 委员会是许多规划和评估工作（例如共享资源咨询小组（SR AG）） 和成员资格），供科学指导和执行委员会审议和采取行动。 委员会。总的来说，来自这些咨询实体的反馈使西尔维斯特能够获得有效的内部 和外部建议，确定优先事项，作出决定，并确定和评估中心的战略计划， 活动这些活动推动了西尔维斯特的使命和愿景，最大限度地提高了中心的能力， 癌症研究议程，保持最高标准/质量的护理和研究，并提供其独特的 集水区，一个无与伦比的多样性。

PROJECT SUMMARY: LEADERSHIP, PLANNING, AND EVALUATION Stephen D. Nimer, MD, was appointed as Sylvester Comprehensive Cancer Center (Sylvester) Director in 2012. Under his leadership, Sylvester has experienced exponential growth, driven by its dedicated leadership team, its highly engaged and experienced External Advisory Board (EAB), its productive relationship with University leadership, and its adherence to a carefully constructed 2014-2018 Strategic Plan with clear standards, timelines, goals, and deliverables. Nimer leads Sylvester with the assistance of a senior leadership team comprised of a Deputy Director, six Associate Directors, an Associate Vice President, and Physician-in-Chief for the Oncology Service Line. Collectively, this team provides thoughtful and important counsel to the Director, including strategies that promote the growth of Sylvester’s basic, translational, clinical, and population science research portfolio; education and training activities; community outreach and engagement capabilities; shared resource support; and its ability to define new research directions and create new programs and funding opportunities for its members. In addition to the guidance offered by Sylvester’s robust senior leadership team, Sylvester has seven internal review committees that provide recommendations and oversee the implementation of Sylvester’s activities and strategic plans; including the Executive Committee, Space Allocation, Intramural Funding Program (IFP), Scientific Steering Committee (SSC), Clinical Research Internal Advisory Board (CRIAB), Cancer Education Leadership Council (CELC), and Community Outreach and Engagement Internal Advisory Board (COE IAB). Additionally, two external advisory entities—the External Advisory Board (EAB) and the Board of Overseers (BOO)—provide advice and expertise that is critical to Sylvester’s success. Supplementing Sylvester’s senior leadership and internal and external advisory committees are the many planning and evaluation efforts (e.g. Shared Resource Advisory Groups (SR AG) and Membership), which are presented for consideration and action to the Scientific Steering and Executive Committees. In aggregate, feedback from these advisory entities allows Sylvester to obtain effective internal and external advice, set priorities, make decisions, and define and evaluate the Center’s strategic plans and activities. These activities drive Sylvester’s mission and vision maximizing the Center’s ability to advance a full cancer research agenda, maintain the highest standard/quality of care and research, and serve its unique catchment area, one with unparalleled diversity.